Anebulo Pharmaceuticals (ANEB) Stock Price, Quote, News & History

Comments

Anebulo Pharmaceuticals Inc (ANEB) Stock Price, Quote, News & History

ANEBOTCPK

Trade with Public

$0.4700

0.1130.56%

Last update: Mar 11, 11:32 AM

OverviewNews Earnings Analyst Ratings Insider Trades Short Interest

Key Statistics

Open

Volume / Avg.

13.31K / 109.02K

Day Range

- - -

52 Wk Range

0.35 - 3.42

Market Cap

$19.17M

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

1.16

Recent Anebulo Pharmaceuticals Inc News

Crude Oil Jumps 2%; Chicago Fed National Activity Index Improves Slightly In September

Avi Kapoor

US Stocks Higher; Nasdaq Surges Over 100 Points

Avi Kapoor

Deal Dispatch: Need M&A Approval? FCC Chair Explains How To Get It

The "Jimmy Kimmel Live" drama coincided with reports of tit-for-tat maneuvering between the FCC and corporations desperate for deal approval.

Anthony Noto

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-5.84M

Investing Cash Flow (TTM)

Financing Cash Flow (TTM)

-116.66K

Free Cash Flow (TTM)

-5.84M

Capital Expenditure (TTM)

Net Change in Cash (TTM)

-5.96M

Analyst Rating and Forecast

2.0

Sell

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$9.31M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

2.31

Earnings Yield % (TTM)

-40.00%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$0.19

Company Debt

Total Debt

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$9.04M

Debt to Equity

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

Volume / Avg.

13.31K / 109.02K

Day Range

- - -

52 Wk Range

0.35 - 3.42

Market Cap

$19.17M

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

1.16

About

Sector

Health Care

Industry

Pharmaceuticals

Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the neg...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Anebulo Pharmaceuticals (ANEB) stock?

You can purchase shares of Anebulo Pharmaceuticals (OTCPK:ANEB) through any online brokerage.

View our list of the best stock brokerages

Who are Anebulo Pharmaceuticals (ANEB) competitors?

There are no as such competitors for Anebulo Pharmaceuticals.

What is the forecast, or price target, for Anebulo Pharmaceuticals (ANEB) stock?

Anebulo Pharmaceuticals has a consensus price target of $7.00.

What is the current price for Anebulo Pharmaceuticals (ANEB)?

The stock price for Anebulo Pharmaceuticals (OTCPK: ANEB) is $0.47 last updated March 11, 2026 at 11:32 AM EDT.

Does Anebulo Pharmaceuticals (ANEB) pay a dividend?

There are no upcoming dividends for Anebulo Pharmaceuticals.

When is Anebulo Pharmaceuticals (OTCPK:ANEB) reporting earnings?

Anebulo Pharmaceuticals does not have any upcoming earnings scheduled.

Is Anebulo Pharmaceuticals (ANEB) going to split?

There is no upcoming split for Anebulo Pharmaceuticals.

What sector and industry does Anebulo Pharmaceuticals (ANEB) operate in?

Anebulo Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCPK.

Key Statistics

Open

Volume / Avg.

13.31K / 109.02K

Day Range

- - -

52 Wk Range

0.35 - 3.42

Market Cap

$19.17M

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

1.16

Recent Anebulo Pharmaceuticals Inc News

Crude Oil Jumps 2%; Chicago Fed National Activity Index Improves Slightly In September

Avi Kapoor

US Stocks Higher; Nasdaq Surges Over 100 Points

Avi Kapoor

Deal Dispatch: Need M&A Approval? FCC Chair Explains How To Get It

The "Jimmy Kimmel Live" drama coincided with reports of tit-for-tat maneuvering between the FCC and corporations desperate for deal approval.

Anthony Noto